15th Jun 2007 13:26
Synexus Clinical Research PLC15 June 2007 SYNEXUS CLINICAL RESEARCH PLC (the "Company") GRANT OF OPTIONS On 14 June 2007, options over 159,178 ordinary shares of 10p each in SynexusClinical Research PLC were granted to Paul McCluskey, a director of the Company,in accordance with the Rules of the EMI Scheme and Unapproved Share OptionScheme. The options are exercisable in the period 14 June 2007 to 14 June 2017at a price of 62.5p per share. As a result of this grant, Paul McCluskey now hold options over a total of275,468 ordinary shares in the Company representing his total interest in theshare capital of the Company. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Synectics